What's New

News & Updates
August 19, 2020

China grants patent to COVID-19 vaccine

China has granted a patent to CanSino Biologics Inc. for its COVID-19 vaccine candidate – Ad5-nCOV. The patent application was filed on March 18, 2020 and the patent was granted on August 11, 2020. Reportedly, Phase II trials of the vaccine have been completed and CanSino is in talks with Russia, Brazil and Chile to launch Phase III trials.

  • Non Solicitation
  • Data Privacy & Protection
  • Conflict of Interest Policy
  • Data & Document Retention Practice
  • Firm Management Policy
  • Liability
  • Disclaimer
  • Privilege
  • Copyright
  • Billing Policy